Compile Data Set for Download or QSAR
Report error Found 299 of affinity data for UniProtKB/TrEMBL: Q8N1A2
TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748489BDBM748489(US20250188030, Compound C71)
Affinity DataKi:  0.0100nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748458BDBM748458(US20250188030, Compound C40)
Affinity DataKi:  0.0200nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748381BDBM748381(US20250188030, Compound A38)
Affinity DataKi:  0.0200nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748380BDBM748380(US20250188030, Compound A37)
Affinity DataKi:  0.0200nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748570BDBM748570(US20250188030, Compound I17)
Affinity DataKi:  0.0200nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748450BDBM748450(US20250188030, Compound C31)
Affinity DataKi:  0.0200nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748527BDBM748527(US20250188030, Compound E3)
Affinity DataKi:  0.0300nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748569BDBM748569(US20250188030, Compound I16)
Affinity DataKi:  0.0300nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748416BDBM748416(US20250188030, Compound B31)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748478BDBM748478(US20250188030, Compound C60)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748472BDBM748472(US20250188030, Compound C54)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748488BDBM748488(US20250188030, Compound C70)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748487BDBM748487(US20250188030, Compound C69)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748420BDBM748420(US20250188030, Compound B35)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748419BDBM748419(US20250188030, Compound B34)
Affinity DataKi:  0.0400nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748495BDBM748495(US20250188030, Compound C77)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748508BDBM748508(US20250188030, Compound C90)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748491BDBM748491(US20250188030, Compound C73)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748475BDBM748475(US20250188030, Compound C57)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748423BDBM748423(US20250188030, Compound C3)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748422BDBM748422(US20250188030, Compound C2)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748405BDBM748405(US20250188030, Compound B20)
Affinity DataKi:  0.0500nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748461BDBM748461(US20250188030, Compound C43)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748509BDBM748509(US20250188030, Compound C91)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748411BDBM748411(US20250188030, Compound B26)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748455BDBM748455(US20250188030, Compound C37)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748429BDBM748429(US20250188030, Compound C9)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748497BDBM748497(US20250188030, Compound C79)
Affinity DataKi:  0.0600nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748479BDBM748479(US20250188030, Compound C61)
Affinity DataKi:  0.0700nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748427BDBM748427(US20250188030, Compound C7)
Affinity DataKi:  0.0700nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748505BDBM748505(US20250188030, Compound C87)
Affinity DataKi:  0.0700nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748485BDBM748485(US20250188030, Compound C67)
Affinity DataKi:  0.0700nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748500BDBM748500(US20250188030, Compound C82)
Affinity DataKi:  0.0700nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748496BDBM748496(US20250188030, Compound C78)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748401BDBM748401(US20250188030, Compound B16)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748589BDBM748589(US20250188030, Compound J16)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748435BDBM748435(US20250188030, Compound C16)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748528BDBM748528(US20250188030, Compound E4)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748584BDBM748584(US20250188030, Compound J11)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748501BDBM748501(US20250188030, Compound C83)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748481BDBM748481(US20250188030, Compound C63)
Affinity DataKi:  0.0800nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748415BDBM748415(US20250188030, Compound B30)
Affinity DataKi:  0.0900nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748409BDBM748409(US20250188030, Compound B24)
Affinity DataKi:  0.0900nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748456BDBM748456(US20250188030, Compound C38)
Affinity DataKi:  0.0900nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748407BDBM748407(US20250188030, Compound B22)
Affinity DataKi:  0.0900nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748390BDBM748390(US20250188030, Compound B5)
Affinity DataKi:  0.0900nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748440BDBM748440(US20250188030, Compound C21)
Affinity DataKi:  0.0900nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748402BDBM748402(US20250188030, Compound B17)
Affinity DataKi:  0.100nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748437BDBM748437(US20250188030, Compound C18)
Affinity DataKi:  0.100nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetHistone acetyltransferase KAT2A(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 748471BDBM748471(US20250188030, Compound C53)
Affinity DataKi:  0.100nMAssay Description:KAT2A/B Assay Protocol:A) Compound preparation1) Prepare 10 mM stock solutions in 100% DMSO from solid material.2) Serial dilute 10 mM, 1 mM, 0.1 or ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

Displayed 1 to 50 (of 299 total ) | Next | Last >>
Jump to: